Sandhoff Disease
Showing 1 - 25 of >10,000
Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II Trial in Durham (DUOC-01)
Recruiting
- Adrenoleukodystrophy
- +11 more
- DUOC-01
-
Durham, North CarolinaDuke University Medical Center
Oct 24, 2022
A Natural History Study of the Gangliosidoses
Recruiting
- Tay-Sachs Disease
- +4 more
-
Minneapolis, MinnesotaUniversity of Minnesota - Pediatric Genetics and Metabolism
Feb 28, 2022
GM1 and GM2 Gangliosidosis PROspective Neurological Disease
Recruiting
- GM1 Gangliosidosis
- +2 more
-
Oakland, California
- +12 more
Nov 16, 2022
GM2 Gangliosidosis, Supportive Care Trial in Kashan, Mashhad, Tehran (Miglustat)
Recruiting
- GM2 Gangliosidosis
- Supportive Care
-
Kashan, Isfahan, Iran, Islamic Republic of
- +2 more
Oct 23, 2022
The Natural History of Metachromatic Leukodystrophy
Recruiting
- MLD
- +26 more
- Palliative Care
- Hematopoetic Stem Cell Transplantation
-
Pittsburgh, PennsylvaniaThe Program for the Study of Neurodevelopment in Rare Disorders,
Nov 2, 2021
Tay-Sachs Disease, Sandhoff Disease Trial in Boston, Worcester (AXO-AAV-GM2 Starting Dose, AXO-AAV-GM2 Low Dose, AXO-AAV-GM2
Recruiting
- Tay-Sachs Disease
- Sandhoff Disease
- AXO-AAV-GM2 Starting Dose
- +3 more
-
Boston, Massachusetts
- +1 more
Jan 26, 2021
GM1 Gangliosidoses, GM2 Gangliosidoses, Tay-Sachs Disease Trial in Minneapolis (miglustat, Ketogenic Diet)
Terminated
- GM1 Gangliosidoses
- +3 more
- miglustat
- Ketogenic Diet
-
Minneapolis, MinnesotaUniversity of Minnesota
Mar 18, 2021
Gangliosidoses, GM1 Gangliosidosis, Morquio B Disease Trial in Hochheim
Recruiting
- Gangliosidoses
- +8 more
-
Hochheim, HE, GermanySphinCS Lyso gemeinnützige UG (haftungsbeschränkt)
Nov 5, 2020
Tay-Sachs Disease Sandhoff Disease Trial in Worldwide (venglustat GZ402671, )
Active, not recruiting
- Tay-Sachs Disease Sandhoff Disease
- venglustat GZ402671
- placebo
-
Los Angeles, California
- +23 more
Jan 31, 2022
Glycosphingolipid and Glycoprotein Lysosomal Storage Disorders
Recruiting
- Neurological Regression
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 14, 2023
Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (drug, procedure,
Completed
- Adrenoleukodystrophy
- +8 more
- Clofarabine
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jul 10, 2019
Infantile GM2 Gangliosidosis (Disorder) Trial in Kingston (TSHA-101)
Active, not recruiting
- Infantile GM2 Gangliosidosis (Disorder)
- TSHA-101
-
Kingston, Ontario, CanadaQueen's University/Kingston Health Sciences Centre
Sep 12, 2022
Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2)
Active, not recruiting
- Hepato-splenomegaly
- +3 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Peripheral Artery Disease Trial in Aurora (Intervention A - Vascular Care + site 6MWT administration, Intervention B - Standard
Recruiting
- Peripheral Artery Disease
- Intervention A - Vascular Care + site 6MWT administration
- +3 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jul 22, 2021
GM2 Gangliosidosis Trial in Boston
Recruiting
- GM2 Gangliosidosis
-
Boston, MassachusettsMassachusetts General Hospital
Sep 8, 2020
Diabetes, Type 2 Trial in Hong Kong (Simvastatin 10mg, Ezetimibe 10mg)
Enrolling by invitation
- Diabetes Mellitus, Type 2
- Simvastatin 10mg
- Ezetimibe 10mg
-
Hong Kong, Hong KongDiabetes Centre, 2/F, Block L, Department of Medicine, Queen Mar
Nov 21, 2022
Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (Stem Cell Transplant,
Completed
- Adrenoleukodystrophy
- +10 more
- Stem Cell Transplant
- Busulfan, Cyclophosphamide, Antithymocyte Globulin
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Pompe Disease Trial in New York, Fairfax (biological, drug, other)
Not yet recruiting
- Pompe Disease
- Cipaglucosidase alfa
- +3 more
-
New York, New York
- +1 more
Nov 2, 2023
Chronic Rhinosinusitis Associated With Inflammatory Bowel
Not yet recruiting
- Intestinal Inflammation
- Rhinosinusitis
- Observational study
- (no location specified)
Nov 21, 2023
Oral Lichen Planus, Topical Sulfasalazine, Corticosteroids Trial in Cairo (sulfasalazine 500 MG, corticosteroids)
Active, not recruiting
- Oral Lichen Planus
- +2 more
- sulfasalazine 500 MG
- corticosteroids
-
Cairo, EgyptFaculty of Dentistry, Cairo University
Sep 23, 2023
COrSIcA: Disease Measurement
Not yet recruiting
- Anal Intraepithelial Neoplasia
- +2 more
- Physical examination
- (no location specified)
May 4, 2023
Crohn's Disease Trial (MR Enterography (MRE))
Not yet recruiting
- Crohn's Disease
- MR Enterography (MRE)
- (no location specified)
Nov 13, 2023
Gastroesophageal Reflux Disease Trial in Assiut (Nursing Teaching)
Not yet recruiting
- Gastroesophageal Reflux Disease
- Nursing Teaching
-
Assiut, EgyptFaculty of Nursing Assiut University
Jul 10, 2023
Patients With Von Hippel Lindau Disease
Not yet recruiting
- Von Hippel Lindau Disease
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2023